His potential violations include failing to keep complete records, failing to properly document inventory, failing to indicate the date received on two invoices and failing to properly indicate the dispositions within the patient files, among other violations, according to a news release.
Dr. Ramsden must also surrender his CEO registration for Schedule II and III controlled substances for five years.
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.